Share
A surgeon removes a tumor visible on a monitor. Accelerating cancer treatments would be one goal of the Advanced Research Projects Agency-Health that President Joe Biden has proposed creating. Matt Rourke/AP
Biden wants $6.5 billion for new health agency to speed treatments
Apr. 9, 2021 , 5:30 PM
The Biden administration today began to flesh out a proposal for a new agency modeled on the military’s Defense Advanced Research Projects Agency (DARPA) that would seek to speed the development of medical treatments by funding risky, innovative projects. The agency, dubbed ARPA-Health (ARPA-H), would be housed at the National Institutes of Health and have a 2022 budget of $6.5 billion, according to a White House spending request released today.
Vizgen Secures $37M Series B Financing to Advance Spatial Genomics Through Commercialization of MERSCOPE™ Platform
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Risk Management Solutions Provider Aclaimant Raises $15 million in Financing to Further Growth
forconstructionpros.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forconstructionpros.com Daily Mail and Mail on Sunday newspapers.
Share:
Exicure, Inc. (NASDAQ:XCUR), a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA™) technology, today announced the appointments of Elizabeth (Betsy) Garofalo, M.D. and Mr. Andrew Sassine to its Board of Directors. We are pleased to welcome Betsy and Andrew to our Board at a critical time for Exicure, having made significant progress with the development of cavrotolimod in oncology and XCUR-FXN in Friedreich s ataxia. Betsy s distinguished career and significant clinical development experience and Andrew s financial and institutional investor experience will provide important perspective to our Board, said Timothy P. Walbert, Exicure s Chairman of the Board of Directors. We look forward to the collective experience they will bring as Exicure advances its pipeline of innovative investigational therapies and we look to deliver on the promise of Exicure s proprietary Spherical Nucleic Acid, or SNA technology.
CDC expert proposes China, US mutual vaccine recognition, lifting of travel restrictions
globaltimes.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globaltimes.cn Daily Mail and Mail on Sunday newspapers.